The next steps should include an in-depth exploration of the CB1-mTORC1 interaction in the modulation of both glucose-stimulated insulin secretion and β-cell mass expansion both in human islets and in animal models of type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.